Vetrx Formulations Private Limited
About Vetrx Formulations Private Limited
Data last updated:
Vetrx Formulations Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PTC094955. Its GSTIN is 09AAGCV0102P1Z7 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shipra Tripathi and Sanjeev Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 115/146 Maswanpur Behind Omer Chauraha, Kanpur, Uttar Pradesh, India – 208019.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.54 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹52,200 (net margin 0.3%) and EBITDA of ₹3.64 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 6% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address115/146 Maswanpur Behind Omer Chauraha, Kanpur, Uttar Pradesh, India – 208019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vetrx Formulations Private Limited
The main business activity of Vetrx Formulations is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vetrx Formulations Private Limited FY 2025 filings available
Vetrx Formulations Private Limited reported revenue of ₹1.54 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vetrx Formulations Private Limited
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vetrx Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52,200 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vetrx Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vetrx Formulations are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vetrx Formulations Private Limited
Vetrx Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bestead Lifesciences Private Limited | ₹1.54 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Delhi, India |
| A Klass Drugs and Pharmaceuticals Private Limited | ₹1.54 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | Khamgaon, Maharashtra, India |
| Ace Remedies Private Limited | ₹1.54 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Pune, Maharashtra, India |
| Kunnj Healthcare Private Limited | ₹1.54 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Kalol, Gujarat, India |
| Barfani Baba Pharma Private Limited | ₹1.54 Cr (FY 2020) | •••• | •••• | 1825.0% | •••• | New Delhi, Delhi, India |
| Vetrx Formulations Private Limited this company | ₹1.54 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Kanpur, Uttar Pradesh, India |
| Chaudhary Distributors Private Limited | ₹1.54 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Indore, Madhya Pradesh, India |
| Effibar India Private Limited | ₹1.54 Cr (FY 2024) | •••• | •••• | -64.0% | •••• | Delhi, India |
| Nexzen Formulations Limited | ₹1.54 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Chennai, Tamil Nadu, India |
| Articon Labs Private Limited | ₹1.54 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Styla Pharmaceutical Private Limited | ₹1.54 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Vetrx Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vetrx Formulations Private Limited
Vetrx Formulations Private Limited is audited by D P SINGH & COMPANY for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D P SINGH & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vetrx Formulations Private Limited
Vetrx Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shipra Tripathi | Director | 13 Jul 2017 | 9 Years 2 Months | Current |
| Sanjeev Mishra | Director | 13 Jul 2017 | 9 Years 2 Months | Current |
Ownership and Shareholding of Vetrx Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vetrx Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2024 | Hdfc Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Vetrx Formulations Private Limited
Vetrx Formulations Private Limited has a workforce of 4 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vetrx Formulations Private Limited
Vetrx Formulations Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Sanjeev Mishra was appointed as Director on 13 Jul 2017.
Credit Ratings, Litigation & Regulatory Alerts for Vetrx Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vetrx Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vetrx Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vetrx Formulations Private Limited
Vetrx Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCV0102P1Z7 | Uttar Pradesh | Active | 26 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vetrx Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vetrx Formulations Private Limited
Vetrx Formulations is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 July 2017 (9+ years old) and is registered under CIN U51909UP2017PTC094955.
Vetrx Formulations reported revenue of ₹1.54 Cr for FY 2025 (down 12% YoY).
Vetrx Formulations has 2 current directors:
- Shipra Tripathi - Director
- Sanjeev Mishra - Director
Vetrx Formulations reported a net profit of ₹52,200 (net margin 0.3%) and EBITDA of ₹3.64 Lakh (EBITDA margin 2.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vetrx Formulations is 8% over three years and 6% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vetrx Formulations is 09AAGCV0102P1Z7, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Vetrx Formulations is U51909UP2017PTC094955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vetrx Formulations was incorporated on 13 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Vetrx Formulations by revenue are Bestead Lifesciences Private Limited, A Klass Drugs and Pharmaceuticals Private Limited, Ace Remedies Private Limited, Kunnj Healthcare Private Limited, Barfani Baba Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Sanjeev Mishra was appointed as Director on 13 Jul 2017. Shipra Tripathi was appointed as Director on 13 Jul 2017.
The registered office of Vetrx Formulations is at 115146 Maswanpur Behind Omer Chauraha, Kanpur, Uttar Pradesh, India – 208019.